Faculty who have authored publication Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.
Name | Title | Department | Institution |
---|---|---|---|
Nirav N. Shah MD | Associate Professor | Medicine | Medical College of Wisconsin |